Skip to main content Skip to search Skip to main navigation

Water Qualities – Drinking Water as Source Water

Excerpt from the GMP Compliance Adviser, Chapter 5.A.2: Drinking water as source water

6 min. reading time | by Fritz Röder
Published in LOGFILE 07/2025

Pharmaceutical water has a unique position in pharmaceutical industry. As raw materials and excipients are only used after quality control and subsequent release, pharmaceutical water is used immediately after production. For this reason, pharmaceutical water is considered extremely critical. Three types of water are of particular interest: Drinking water as source water, purified water (PW) and water for injections (WFI). In today’s feature we report on drinking water as source water. In future LOGFILES, we will report on PW and WFI.

Keep up to date with Water qualities by taking a closer look at chapter 5.A: Water Qualities in your GMP Compliance Adviser, the most comprehensive online GMP knowledge portal worldwide.


Pharmaceutical water occupies a unique position in the pharmaceutical industry. Raw materials and excipients are normally only used after quality control and subsequent release. Pharmaceutical water, however, is always used immediately after it has been produced because microbiological approval can take several days. For this reason, pharmaceutical water is regarded as being extremely critical, and there are many specifications in the pharmacopoeias and GMP regulations.Three water types are of particular interest:

  • Drinking water as source water
  • Purified water (PW)
  • Water for injections (WFI)

In addition, until 2019, the European Pharmacopoeia included the water quality "highly purified water (HPW)", which has been deleted from the pharmacopoeia. Nevertheless, such systems still exist in the industry.


Drinking Water as Source Water

In accordance with the regulations, drinking water is the source water, i.e. the raw product used to produce other water qualities. Drinking water is, therefore, a raw material and as such must undergo an incoming goods inspection. Waterworks analyses are often the only proof available for the quality of drinking water. In general, however, additional on-site monitoring is expected as the samples for these analyses are taken by the utilities at their waterworks or elevated tanks. The distance that drinking water travels from the elevated tank to the point of entry into an ultrapure water system can be several kilometres. Drinking water can be contaminated along the way. In addition, the supplier's responsibility ends at the pharmaceutical company's transfer point. In the case of the monitoring mentioned above, microbiology is usually the main concern. However, other parameters may be added. For example, the WHO guidelines (Figure 1) state:

Figure 1                Excerpts from ‘Annex 2 WHO good manufacturing practices: water for pharmaceutical use’ for the production of drinking water.

Accordingly, a drinking water network is not subject to qualification. The current version of the German Drinking Water Ordinance of 2023 explicitly states that systems for the distribution of drinking water must be planned, constructed and operated at least in accordance with the generally recognised rules of technology (§13). Accordingly, suitable piping materials must be always used and appropriate safety devices (e.g.  backflow preventers according to EN 1717) installed when building new facilities.

It is also important to know the source of the drinking water because there are major differences between surface water and good-quality well water. The main differences between the two sources are listed below.
 

Ground water

Water from the depths of the earth, well filtered, consistent quality:

  • Low turbidity
  • Constantly low temperatures
  • Generally high salt content, geogenic
  • No organic contamination
  • No anthropogenic impurities
  • Only treated if necessary
  • No parameter fluctuation
  • Mostly a low bioburden
     

Surface water

Water from the surface of the earth, rivers, lakes, etc.:

  • High turbidity, high colloid index
  • Temperature differences in summer/winter
  • Parameter fluctuation possible
  • Contaminated with different substances
  • Can contain humic substances
  • Often burdened with organic substances
  • Often microbiologically burdened, high TOC
     

If you have the choice between these two qualities of drinking water, you should always choose groundwater as the starting quality, as it is much less variable. As a result, a pure water system is much easier to operate.
 


Quality requirements

Drinking water is water that meets the statutory quality requirements for human consumption and use. However, the water can contain substances that have to be removed prior to the generation of pharmaceutical water. Typical examples are the hardness of water or its organic contamination. Water softeners are normally used to treat hard water. Organic contamination, however, is often only noticed when the system membrane is blocked, and fluctuations are possible at any time. When systems that use modern membrane technology are used for cold WFI production, this parameter has particular significance and requires proper monitoring and documentation.

The quality of drinking water in Germany is defined in the German Drinking Water Ordinance. The permissible limits for substances found in drinking water and specifications on the scope, frequency and implementation of testing are outlined in the appendices of the Drinking Water Ordinance. Comparison of the in-house requirements with the latest version of the Drinking Water Ordinance (or other national regulations, as applicable) on a regular basis is recommended to ensure that they meet the requirements.

The microbiological quality of the drinking water is an important parameter regarding pharmaceutical use.

  • Escherichia coli and enterococci (faecal streptococci) must not be detectable in 100 ml water.
  • Pseudomonas aeruginosa and legionella, on the other hand, may be present in drinking water in small numbers

The Ordinance lists the total microbial count as an indicator parameter and the colony count must not change in any significant way. The Drinking Water Ordinance, however, also stipulates a limit of 100 CFU/ml for the water at the point of use of the consumer. This limit should be the feed water action limit for manufacturers of medicinal products.

There are also limit values and indicator parameters for heavy metals, organic compounds and other physical parameters, e.g. electric conductivity. For detailed information, please refer to Annex 2 and 3 of the Drinking Water Ordinance. In practice, checking the respective critical values and/or fluctuating chemical and physical parameters of the drinking water before use can suffice. These parameters can include nitrate and organic contamination, for example.

From April 2024, it will no longer be necessary to test ultrapure water for nitrate in most cases. However, elevated nitrate levels in drinking water can be an indicator of pesticide use in agriculture (depending on the season).

In addition to supplying the pharmaceutical water treatment system, drinking water is also used for pre-rinsing the equipment and containers during cleaning cycles. However, if drinking water is too hard, it may not be suitable (or a water softener is connected upstream). Drinking water can also be used during the initial stages of active substance manufacture (Figure 2). The EMA Guideline on the quality of water for pharmaceutical use contains further details.

Figure 2                 Uses of drinking water in the pharmaceutical industry.


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Fritz Röder
Fritz Röder

You may also be interested in the following articles:

Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
News: Europe

EU: Council Adopts the Pharmaceutical Package

On 28 September 2026, the Council of the European Union adopted the EU pharmaceutical package, marking another important step in the legislative process for the comprehensive reform of EU pharmaceutical legislation.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT